Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
12000 participants
OBSERVATIONAL
2020-01-20
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Anxiety on Coronary Microcirculatory Function in Hypertensive Patients
NCT04960371
Dysautonomia in Patients Post COVID-19 Infection
NCT04716465
Anxiety and Cardiovascular Autonomic Control
NCT00005471
Mental Stress, Autonomic Function, and Heart Disease
NCT00005524
Anxiety and Vagal Control of the Heart in Coronary Disease
NCT00006311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
After outbreak
No interventions assigned to this group
Past 3 months
No interventions assigned to this group
Last year
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Qilu Hospital of Shandong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pan-Pan Hao
Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Binzhou Medical Universty
Binzhou, Shandong, China
Heze Municipal Hospital
Heze, Shandong, China
Shandong University Qilu Hospital
Jinan, Shandong, China
Jinan Central Hospital, Shandong University
Jinan, Shandong, China
First Hospital Affiliated with Shandong First Medical University
Jinan, Shandong, China
Shandong Provincial Hospital, Shandong University
Jinan, Shandong, China
The Second Hospital of Shandong University
Jinan, Shandong, China
Jining Hospital of Traditional Chinese Medicine
Jining, Shandong, China
Qihe People's Hospital
Qihe, Shandong, China
Affiliated Hospital of Qingdao University Medical College
Qingdao, Shandong, China
Weihai Municipal Hospital
Weihai, Shandong, China
Central Hospital of Zibo
Zibo, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Min Feng, MD, PhD
Role: primary
Lujing Meng, MD
Role: primary
Xin Zhang, MD
Role: primary
kun Wen, MD
Role: primary
Zhengyan Qu, MD
Role: primary
Jianjun Lu, MD
Role: primary
Liang Shan, MD
Role: primary
Lei Cao, MD
Role: primary
Bo Li, MD, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019nCoV-CVD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.